This opportunity is no longer accepting applications.
grant PAR-24-198

Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Amyloid Beta Immunotherapy (R01 - Clinical Trial Not Allowed)

This grant aims to support research on understanding how brain blood vessels respond to treatments aimed at reducing beta-amyloid, a substance linked to Alzheimer's disease. The focus is on uncovering the cellular and molecular processes involved, especially those that may lead to imaging abnormalities. The ultimate goal is to identify ways to protect the blood-brain barrier and brain blood ve…

This initiative is designed to promote discovery of cellular and molecular mechanisms that underlie brain blood vessels responses to passive anti-beta-amyloid immunotherapy that result in amyloid-related imaging abnormalities (ARIA). The goal is to establish an understanding of molecular mechani…

Funding Source

Agency: National Institutes of Health
Program: SBIR

Awards & funding

Award Ceiling: $500,000
Award Amount: $500,000

Dates

Opportunity Released: April 10, 2024
Open for Submission: April 10, 2024
Submission Deadline: November 5, 2024
Application Window Closes: November 5, 2024

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.